Historical record - last NADAC effective date: 7/1/2017

Product Information

LANOXIN 125 MCG TABLET is a brand product labeled by Advanz Pharma (US) Corp., priced at $11.3651 per EA under NDC 59212024255. Its NADAC has been published 109 times since Jun 15, 2016.

FDA first approved this application on Sep 30, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the digoxin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LANOXIN 125 MCG TABLET

digoxin
$11.3651per EA
High Outlier

Strength

.125 mg/1

NDC

59212024255

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

7/1/2017

Active Ingredients

DIGOXIN

Approval Type

New Drug (NDA)

FDA Application

NDA020405

FDA Approved

9/30/1997

TE Code

AB

On Market Since

9/30/2012

Pharmacological Classes

Cardiac Glycoside
Cardiac Glycosides

Price Statistics

The NADAC for LANOXIN 125 MCG TABLET has been published 109 times since Jun 15, 2016, and over the history we have for it it has risen 61.5%. The table below summarizes its recorded NADAC range and movement.

Current price$11.3651 per EA
All-time high$11.3651 (Jul 11, 2018)
All-time low$6.9038 (Aug 17, 2016)
Median price$10.0105
Average price$10.1388
Largest weekly change+45.0% (Oct 26, 2016)
Weeks tracked109
Tracking sinceJun 15, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+61.5%

Last surveyed Jul 11, 2018 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LANOXIN 125 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LANOXIN 125 MCG TABLET, manufactured by Advanz Pharma (US) Corp., is $11.3651 per EA (NDC 59212024255), effective Jul 11, 2018.

How has the price of LANOXIN 125 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LANOXIN 125 MCG TABLET has risen 61.5%. It has been tracked across 109 weekly CMS publications since Jun 15, 2016.

What are the highest and lowest recorded NADAC prices for LANOXIN 125 MCG TABLET?

Since Jun 15, 2016, the NADAC for LANOXIN 125 MCG TABLET has ranged from a low of $6.9038 (Aug 17, 2016) to a high of $11.3651 (Jul 11, 2018), with a median of $10.0105 per EA.

Are there cheaper alternatives to LANOXIN 125 MCG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LANOXIN 125 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LANOXIN 125 MCG TABLET?

LANOXIN 125 MCG TABLET (NDC 59212024255) is labeled by Advanz Pharma (US) Corp., and CMS classifies it as a brand product.